ArticleMolecular therapy : the journal of the American Society of Gene Therapy2016

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Kari Pollock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.